PATENT CLAIM ANALYSIS

Application Number: 16270728
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["546", "112000"]

Abstract:
Novel deuterium-containing chemical compounds are provided. They are glucosylceramide (GSC) synthase inhibitors and are useful for treating various types of lysosomal storage diseases including Fabry's disease, Gaucher's disease and Parkinson's disease, or related diseases and conditions. Also described are pharmaceutical compositions, and methods of preparation and use thereof.

Claim (Index 3):
The compound of  claim 1 , wherein each of R 2  in the compound is D and each of R 1  is H, having the structural Formula (III):

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.40476
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15546320', '13652016', '14689267', '15477569', '15927579']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7875115773128305
- 35 USC 102 Novelty (BERT): 0.5088869644981248
- Combined Prediction Score: 0.7596491160313599
- Mean Citation Score: 255.070752
- Max Citation Score: 290.1744700000001
- Similarity Product: 214.65456590116628

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test